Maven Securities LTD reduced its stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) by 91.1% in the 3rd quarter, Holdings Channel reports. The fund owned 11,146 shares of the company’s stock after selling 113,854 shares during the period. Maven Securities LTD’s holdings in Guardian Pharmacy Services were worth $292,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors also recently bought and sold shares of the stock. Ameritas Investment Partners Inc. boosted its position in Guardian Pharmacy Services by 26.5% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after purchasing an additional 345 shares in the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of Guardian Pharmacy Services by 7.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after purchasing an additional 805 shares in the last quarter. Police & Firemen s Retirement System of New Jersey increased its holdings in shares of Guardian Pharmacy Services by 76.8% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock valued at $52,000 after purchasing an additional 1,062 shares in the last quarter. State of Alaska Department of Revenue acquired a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at $30,000. Finally, Parkside Financial Bank & Trust lifted its stake in shares of Guardian Pharmacy Services by 70.5% in the 3rd quarter. Parkside Financial Bank & Trust now owns 3,248 shares of the company’s stock valued at $85,000 after purchasing an additional 1,343 shares during the period.
Guardian Pharmacy Services Stock Up 3.5%
Shares of GRDN opened at $34.07 on Wednesday. Guardian Pharmacy Services, Inc. has a 52-week low of $19.17 and a 52-week high of $37.43. The stock has a market cap of $2.16 billion, a PE ratio of 44.25 and a beta of 0.85. The firm’s fifty day moving average is $32.02 and its two-hundred day moving average is $29.54.
Analysts Set New Price Targets
Several research firms recently commented on GRDN. Weiss Ratings restated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research report on Monday, December 29th. Raymond James Financial reiterated an “outperform” rating and issued a $40.00 price objective on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Oppenheimer increased their target price on shares of Guardian Pharmacy Services from $35.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, March 12th. Truist Financial raised their target price on Guardian Pharmacy Services from $34.00 to $38.00 and gave the company a “buy” rating in a research report on Thursday, March 12th. Finally, Stephens lifted their price target on Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a research note on Wednesday, January 14th. Five equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $38.00.
View Our Latest Report on Guardian Pharmacy Services
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.
Read More
Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report).
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
